This inventor holds 2 USPTO granted patents. Top assignee: University of Iowa Research Foundation. Active years: 1993-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-1995
Title: Innovations of Mitchell G Gaver in Muscular Dystrophy Research
Introduction
Mitchell G Gaver is a notable inventor based in Cockeysville, MD (US). He has made significant contributions to the field of muscular dystrophy research, holding 2 patents that focus on the dystrophin-glycoprotein complex in mammalian skeletal muscle. His work aims to enhance the understanding and diagnosis of muscular dystrophy, a condition that affects many individuals worldwide.
Latest Patents
Gaver's latest patents revolve around the invention of methods for measuring non-dystrophin proteins and diagnosing muscular dystrophy. The invention pertains to the dystrophin-glycoprotein complex and includes a method for isolating this complex. The components of the complex, along with methods for separating and isolating these components, are also integral to the invention. Furthermore, the invention relates to diagnosing muscular dystrophy by detecting and quantifying the loss of a non-dystrophin component of the dystrophin-glycoprotein complex, with such loss being indicative of muscular dystrophy.
Career Highlights
Mitchell G Gaver is associated with the University of Iowa Research Foundation, where he continues to advance his research and innovations. His work has the potential to significantly impact the diagnosis and treatment of muscular dystrophy, providing hope for many affected individuals.
Collaborations
Gaver collaborates with esteemed colleagues such as Kay Ohlendieck and Steven D Kahl, contributing to a rich environment of research and innovation in the field of muscular dystrophy.
Conclusion
Mitchell G Gaver's contributions to the understanding and diagnosis of muscular dystrophy through his innovative patents highlight the importance of research in this critical area. His work not only advances scientific knowledge but also offers hope for improved diagnostic methods for those affected by this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
